Interests
Greg Mohl , PhD
Biologist
By developing new high-throughput tools, I hope to accelerate precision medicine and work with leaders and policymakers to make genetic therapies more accessible for patients in the U.S. and around the world.
Current Work
Greg Mohl is a postdoctoral fellow at UCSF developing technologies to deliver gene-editing therapies to the brain. His research focuses on high-throughput screening approaches with the goal of creating targeted treatments for neurological diseases.
Personal Hero
My grandparents
Words of Strength
Determination, Focus, Faith and Family
Vision
To bring new genetic medicines to patients, we need innovation in delivery technology and systemic reforms, including robust genetic privacy protections and a stronger development framework for working with the FDA and U.S. healthcare ecosystem.
Strategy
Greg utilizes high-throughput screening methods to accelerate precision medicine and delivery technology development. With these new tools, Greg will collaborate with leaders in the field to help policymakers smooth the way for new genetic medicines.
Impact
As an Atlantic Fellow, Greg aims to learn how the technologies that he develops can be made more accessible to patients in the United States and throughout the world. This knowledge will inform his research and advocacy efforts.
Motivation
Greg has had the privilege to interact with several gene carriers who shared their stories of caring for family members while worrying about their own life and the lives of their children. These patients are counting on us for delivery.
Education & Experience
Greg Mohl, PhD, is a neuroscientist and postdoctoral fellow at UCSF’s Memory and Aging Center, jointly appointed in the Kampmann and Clelland Labs. His research focuses on understanding how tau protein mutations contribute to neurodegenerative diseases and developing nanoparticle-based methods to deliver gene-editing therapies to the brain. Greg earned his PhD in the Tetrad Program at UCSF, where he studied the effects of the V337M tau mutation in neurons, and his BS in Microbiology from Brigham Young University, where he developed novel influenza inhibitors.
Awards & Honors
Send
Greg
a NoteHave ideas for global brain health or a collaboration? I would love to hear from you. Feel free to send an introductory note.
